To provide for the issuance of a Lyme Disease Research Semipostal Stamp.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To provide for the issuance of a Lyme Disease Research Semipostal Stamp., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Education, Transportation.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H6DD1931E91954E5E8CAE950F93D04D1C: 1. Short title This Act may be cited as the Stamp Out Lyme Disease Act.
- Section HA348EF302C7347F6B0791617134A188C: 2. Findings and purpose Congress finds the following: The Centers for Disease Control and Prevention (CDC) estimate that 476,000 Lyme disease cases are...
- Section H3DCB107C945F463ABEF0BF2EBDA6102E: 3. Lyme disease research semipostal stamp The issuance and sale of the Lyme Disease Research Semipostal Stamp shall be governed by the provisions of section...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To provide for the issuance of a Lyme Disease Research Semipostal Stamp., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Education, Transportation
Primary Purpose
This bill, To provide for the issuance of a Lyme Disease Research Semipostal Stamp., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Josh Gottheimer
D-NJ | Primary Sponsor
Legislative Progress
IntroducedMr. Gottheimer (for himself and Mr. Bacon) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology